| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |